Skip to main content
Log in

Predictors of mortality after acute hip fracture

  • Brief Reports
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

Abstract

To identify determinants of mortality after hip fracture, we performed a multicenter, retrospective study of 390 Medicare beneficiaries. Independent predictors of 30-day mortality included a history of congestive heart failure (odds ratio [OR] 32; 95% confidence interval [CI] 5, 192), angina (OR 26; 95% CI 4, 184), or chronic pulmonary disease (OR 11; 95% CI 2, 62). Postoperative use of aspirin was- associated with a reduced risk of mortality (OR 0.24; 95% CI 0.08, 0.70). Cardiovascular events were the presumed cause of 63% of in-hospital deaths. Aspirin may have significant potential to reduce mortality in this population and deserves further study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Myers AH, Robinson EG, Van Natta ML, Michelson JD, Collins K, Baker SP. Hip fractures among the elderly: factors associated with in-hospital mortality. Am J Epidemiol. 1991;134:1128–37.

    PubMed  CAS  Google Scholar 

  2. Koval KJ, Zuckerman JD. Functional recovery after fracture of the hip. J Bone Joint Surg. 1994;76-A:751–8.

    Google Scholar 

  3. Cooper C, Campion G, Melton LJ III. Hip fractures in the elderly: a world-wide projection. Osteoporos Int. 1992;2:285–9.

    Article  PubMed  CAS  Google Scholar 

  4. Schrøder HM, Erlandsen M. Age and sex as determinants of mortality after hip fracture: 3,895 patients followed for 2.5–18.5 years. J Orthop Trauma. 1993;7:525–31.

    Article  PubMed  Google Scholar 

  5. Kenzora JE, McCarthy RE, Lowell JD, Sledge C. Hip fracture mortality: relation to age, treatment, preoperative illness, time of surgery, and complications. Clin Orthop Rel Res. 1984;186:45–56.

    Google Scholar 

  6. Jencks SF, Wilensky GR. The Health Care Quality Improvement Initiative—a new approach to quality assurance in Medicare. JAMA. 1992;268:900–3.

    Article  PubMed  CAS  Google Scholar 

  7. Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin: overview of results of randomized trials in general, orthopedic, and urologic survey. N Engl J Med. 1988;318:1162–73.

    Article  PubMed  CAS  Google Scholar 

  8. Claget GP, Anderson FA, Heit J, Levine MN, Wheeler HB. Prevention of venous thromboembolism. Chest. 1995;108:312S-34S.

    Google Scholar 

  9. Anderson FA, Wheeler HB, Goldberg RJ, Hosmer DW, Forcier A, Patwardhan NA. Physician practices in the prevention of venous thromboembolism. Ann Intern Med. 1991;115:591–5.

    PubMed  Google Scholar 

  10. Mossey JM, Mutran E, Knott K, Craik R. Determinants of recovery 12 months after hip fracture: the importance of psychosocial factors. Am J Public Health. 1989;79:279–86.

    PubMed  CAS  Google Scholar 

  11. Magaziner J, Simonsick EM, Kashner TM, Hebel JR. Kenzora JE. Survival experience of aged hip fracture patients. Am J Public Health. 1989;79:274–8.

    Article  PubMed  CAS  Google Scholar 

  12. Fitzgerald JF, Fagan LF, Tierney WM, Dittus RS. Changing patterns of hip fracture care before and after implementation of the prospective payment system. JAMA. 1987;258:218–21.

    Article  PubMed  CAS  Google Scholar 

  13. Willard JE, Lange RA, Hillis LD. The use of aspirin in ischemic heart disease. N Engl J Med. 1993;327:175–81.

    Google Scholar 

  14. Steering committee of the Physicians’ Health Study Research Group. Final report on the aspirin component of the ongoing Physicians’ Health Study. N Engl J Med. 1989;321:129–35.

    Article  Google Scholar 

  15. Anonymous. Aspirin for prevention of myocardial infarction. Medical Lett. 1995;37:14–6.

  16. Antiplatelet Trialists’ Collaboration. Collaborative overview of randomised trials of antiplatelet therapy, I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ. 1994;308:81–106.

    Google Scholar 

  17. Krumholz HM, Radford MJ, Ellerbeck E, et al. Aspirin in the treatment of acute myocardial infection in elderly Medicare beneficiaries: patterns of use and outcomes. Circulation. 1995;92:2841–7.

    PubMed  CAS  Google Scholar 

  18. MacMahon S, Rodgers A, Collins R, Farrell B. Antiplatelet therapy to prevent thrombosis after hip fracture: rationale for a randomised trial. J Bone Joint Surg Br. 1994;76-B:521–4.

    Google Scholar 

  19. Antiplatelet Trialists’ Collaboration. Collaborative overview of randomised trials of antiplatelet therapy, III: reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. BMJ. 1994;308:235–46.

    Google Scholar 

  20. Imperiale TF, Speroff T. A meta-analysis of methods to prevent venous thromboembolism following total hip replacement. JAMA. 1994;271:1780–5.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported by the Iowa Foundation for Medical Care and the Health Care Financing Agency for which the authors worked.

The views expressed in this article are those of the authors and do not represent an official position of the Iowa Foundation for Medical Care or the Health Care Financing Agency.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nettleman, M.D., Alsip, J., Schroder, M. et al. Predictors of mortality after acute hip fracture. J Gen Intern Med 11, 765–767 (1996). https://doi.org/10.1007/BF02598997

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02598997

Key words

Navigation